JPMorgan Chase JPM.N said on Thursday that long-serving CEO Jamie Dimon's 2024 pay package climbed about 8.3% to $39 million after the bank posted a record profit amid a revival in dealmaking ...

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO CEO & Investor Conference taking place on February 10-11, 2025, in New York City. The company's management will present a ...

Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.

Bio-Techne Corp (NASDAQ:TECH) reported stronger-than-expected earnings for the second quarter of fiscal year 2024, with adjusted earnings per share (EPS) of $0.42, surpassing the forecasted $0.39 ...

Google CEO Sundar Pichai also mentioned YouTube's embrace of podcasting in his scripted comments at the beginning of the earnings call. So did Philipp Schindler, the company's chief business officer.

(Bloomberg) — Match Group Inc. named Zillow Group Inc. co-founder Spencer Rascoff as its new chief executive officer, replacing Bernard Kim who has struggled to end a persistent decline in subscribers ...

Investors interested in arranging a meeting with the Company's management during the conference can register on the BIO CEO & Investor Conference website here. Tonix Pharmaceuticals Holding Corp. * ...

Management is scheduled to give a corporate overview at the BIO CEO & Investor Conference on Tuesday, February 11, 2025 at 10:15 AM EST at the Royale Room and will be available to participate in ...

PRINCETON, N.J., Feb. 4, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...

MILAN (Reuters) - Ferragamo shares slide more than 5% on Tuesday after ... said on Monday it had started the search for a new CEO, who will be in charge of "continuing the activities of brand ...

CARMIEL, Israel, Feb. 4, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of ...

Feb. 04, 2025 (GLOBE NEWSWIRE) -- Uvax Bio, LLC, ("Uvax” or "the Company”) a privately ... today announced the appointment of Chief Business Officer Kevin O'Neill to Interim Chief Executive Officer ...